Amneal Adds Another Complex Generic With TobraDex Approval

Expands Portfolio With Dexamethasone/Tobramycin Ophthalmic Suspension

 
• By Dave Wallace

Amneal has broadened its complex generics portfolio by gaining FDA approval for its generic version of ophthalmic combination medicine TobraDex.

Eye Data Ophthalmic
Amneal has added to its complex generics portfolio with a TobraDex rival • Source: Shutterstock

More from Products

More from Generics Bulletin